6ZG-26292-42174
2 vaccinations
4 coded responses
27 check-ins
3 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 981 / WA
- Registered
- 2022-06-25
- Relationship
- Child or adolescent in my care
- Guardian
- NYM-92680-17534
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-25
Registered in v-safe
-
2022-06-25
Dose 1 — Moderna
-
2022-06-25
Health check-in — day 0, dose 1, under 3Feeling: Good · Site: Redness · Sleepiness, Irritability/cryingUnder 3 check-in
-
2022-06-26
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Sleepiness, Irritability/crying, Loss of appetiteUnder 3 check-in
- 2022-06-27
-
2022-06-28
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Pain · NoneUnder 3 check-in
-
2022-06-29
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Pain · NoneUnder 3 check-in
- 2022-06-30
- 2022-07-01
- 2022-07-02
- 2022-07-09
- 2022-07-16
- 2022-07-25
- 2022-07-30
-
2022-08-06
Dose 2 — Moderna
- 2022-08-06
-
2022-08-07
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Insomnia — Feeling: Good · Site: Swelling/hardnessFree text: Didn't nap today ???MedDRA releases: 2024-11 · check-in free text available
-
2022-08-08
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Asthenia — Feeling: Good · Site: Swelling/hardnessFree text: Lower energy yesterday and today, but not sleepyMedDRA releases: 2024-11 · check-in free text available
- 2022-08-09
- 2022-08-10
- 2022-08-11
- 2022-08-12
- 2022-08-13
- 2022-08-20
- 2022-08-29
- 2022-09-03
- 2022-09-10
-
2022-09-17
Survey response — day 42, dose 2, under 3MedDRA: Rash pruritic, Skin discolouration, Varicella post vaccine — Feeling: Good · Be unable to work or attend schoolFree text: Itchy rashes/spots on back/torso. Assuming it is suspected breakthrough VZV as older sibling is currently suffering from the same issues and is suspected breakthrough VZV. No other symptoms. Still awaiting lab confirmation.MedDRA releases: 2024-11 · check-in free text available
- 2022-11-05
-
2023-02-04
Survey response — 6 months, dose 2, under 3MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-25 | Moderna | No |
| 2 | 2022-08-06 | Moderna | No |
Free text
Release 12 (Under 3) — days 1–6 daily, dose 2, under 3
Systemic reaction (other): Didn't nap today ???
Systemic reaction (other): Lower energy yesterday and today, but not sleepy
Release 12 (Under 3) — day 42, dose 2, under 3
Symptoms: Itchy rashes/spots on back/torso. Assuming it is suspected breakthrough VZV as older sibling is currently suffering from the same issues and is suspected breakthrough VZV. No other symptoms. Still awaiting lab confirmation.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Rash pruritic | · | · | ✓ |
| SD | Skin discolouration | · | · | ✓ |
| SD | Varicella post vaccine | · | · | ✓ |
| SRO | Asthenia | · | · | ✓ |
| SRO | Insomnia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release